During the past decade, Syneos Health conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Syneos Health" #1 sponsor was "InventisBio Co., Ltd" with 1 trials, followed by "Jiangsu Carephar Pharmaceutical Co., Ltd." with 1 trials sponsored, "Pfizer" with 1 trials sponsored, "Ritter Pharmaceuticals, Inc." with 1 trials sponsored and "Taiwan Liposome Company" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "Syneos Health" are "Erosive Esophagitis" (1 trials), "Healthy Volunteers" (1 trials), "Hypogonadism" (1 trials), "Lactose Intolerance" (1 trials) and "OSTEOARTHRITIS OF THE KNEE" (1 trials). Many other conditions were trialed in "Syneos Health" in a lesser frequency.

Most popular intervention types in "Syneos Health" are "Drug" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "D-0120" (1 trials), "DSP" (1 trials), "H008" (1 trials), "H008 placebo" (1 trials) and "Lansoprazole" (1 trials). Other intervention names were less common.

The vast majority of trials in "Syneos Health" are 4 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Syneos Health". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 4 completed trials in Syneos Health, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Syneos Health, 4 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".